复制
收藏
提问
学术
衰弱对胰岛素注射的影响
6天前
全网
文档
学术
百科
知识库
时间不限
自动
来源0
同主题0
来源引用的0
引用来源的0
doi
信任
复制引用信息
危重病人的高血糖症及处理
打开网页
方军
张应天
危重病人无论其既往是否有糖尿病,都经常会出现急性高血糖症和胰岛素抵抗,并成为其他并发症和死亡的高风险因子,而外科普通病人应激性血糖水平不变,可很快纠正,因此不会对机体造成很大影响.近年来,国外在危重病人的血糖控制水平、控制方案及血糖控制的评估等研究中已取得很大进展,并表明强化胰岛素治疗控制血糖至理想水平可明显降低其并发症率及死亡率。
12006-11-30发表Biology
Springer
信任
复制引用信息
译
Medial arterial calcification and its association with mortality and complications of diabetes打开网页
有源文件
J. Everhart
D. Pettitt
W. Knowler
F. A. Rose
P. Bennett
SummaryMedial arterial calcification was studied among 4,553 subjects in a 20-year, longitudinal study of Pima Indians. The prevalence and incidence of medial arterial calcification were highest among men, the elderly, and patients with Type 2 (non-insulin-dependent) diabetes mellitus. Medial arterial calcification was most commonly observed in the feet and appeared to progress proximally. Proportional hazards analysis was used to evaluate risk factors for medial arterial calcification in the feet and to evaluate medial arterial calcification as a risk factor for death and for complications of diabetes. Among diabetic patients, risk factors for medial arterial calcification were impaired vibration perception, long duration of diabetes, and high plasma glucose concentration (p<0.01 for each). Among nondiabetic subjects, age, male gender (p<0.01 for each), and high serum cholesterol concentration (p=0.02) were risk factors for medial arterial calcification. Nondiabetic subjects with medial arterial calcification did not have higher mortality rates than subjects without medial arterial calcification (rate ratio = 0.95, 95% confidence interval = 0.7–1.3). Diabetic patients with medial arterial calcification, compared with diabetic patients without medial arterial calcification, had 1.5-fold the mortality rate (95% confidence interval = 1.0–2.1), 5.5-fold the rate of amputations (95% confidence interval = 2.1–14.1), 2.4-fold the rate of proteinuria (95% confidence interval = 1.3–4.5), 1.7-fold the rate of retinopathy (95% confidence interval = 0.98–2.8), and 1.6-fold the rate of coronary artery disease (95% confidence interval = 0.48–5.4).
2701988-01-01发表MedicineDiabetologia
semanticscholar
信任
复制引用信息
インスリン抵抗性バイオマーカー“セレノプロテインP”の中和抗体の探索およびin vivoでの評価―新規2型糖尿病の治療薬創成を目指して
打开网页
中山華穂
三田雄一郎
吉岡佑弥
西藤有希奈
高橋和彦
野口範子
斎藤芳郎
2014发表Biology
查看更多来源(17)
回答简洁
更专业一些
推荐追问
糖尿病患者如何选择合适的胰岛素治疗方案?
胰岛素治疗对糖尿病患者的生活质量有何影响?
不同类型的糖尿病患者应如何调整胰岛素剂量?
衰弱患者如何提高注射准确性?
如何改善衰弱患者的胰岛素依从性?
衰弱对胰岛素吸收有何具体影响?
文件
学术
专业
以上内容由AI搜集生成,仅供参考